A Phase II, 4-week randomized, double-blind, placebo-controlled clinical trial was conducted
to evaluate the safety and efficacy of the Ampakine compound CX516 as a potential …

The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD)
locus contains one of the last major unidentified autosomal-dominant genes underlying these …

Significant progress has been made in understanding the pre-symptomatic phase of
amyotrophic lateral sclerosis. While much is still unknown, advances in other neurodegenerative …

Using exome sequencing, we identified a p.R191Q amino acid change in the valosin-containing
protein (VCP) gene in an Italian family with autosomal dominantly inherited amyotrophic …

Brain‐derived neurotrophic factor (BDNF) is critical for the function and survival of neurons
that degenerate in the late stage of Alzheimer's disease (AD). There are two forms of BDNF, …

… Joanne Wuu contributed to all aspects of the work described in this article including study
design, obtaining funding, acquiring data, study supervision, statistical analysis, and drafting/…

The evaluation of dystonia requires a reliable rating scale. The widely used Fahn‐Marsden
Scale (F‐M) has not been sufficiently tested across multiple centers and investigators. The …

Placebo‐associated improvements have been previously documented in small series of
Parkinson's disease (PD) patients. Using a strict definition of placebo‐associated improvement, …

Dysfunction of cholinergic basal forebrain (CBF) neurons of the nucleus basalis (NB) is a
cardinal feature of Alzheimer's disease (AD) and correlates with cognitive decline. Survival of …

Nerve growth factor (NGF) is critical for the regulation, differentiation, and survival of basal
forebrain cholinergic neurons that degenerate in the late stage of Alzheimer disease (AD). …